Lamotrigine
Lamotrigine orally disintegrating tablets are indicated for: Epilepsy-adjunctive therapy in patients aged 2 years and older: partial-onset seizures primary generalized tonic-clonic…
Par Pharmaceutical, Inc. Products: Prescription Medications Section, Page 14
Lamotrigine Extended Release
Lamotrigine extended-release is indicated for: adjunctive therapy for primary generalized tonic-clonic seizures and partial-onset seizures with or without secondary generalization in…
Levetiracetam Extended-release (Levetiracetam)
Extended-release levetiracetam tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in patients 12 years of age and older with epilepsy. Extended-release…
Levothyroxine Sodium (LEVOTHYROXINE SODIUM ANHYDROUS)
Levothyroxine Sodium for Injection is indicated for the treatment of myxedema coma. Important Limitations of Use: The relative bioavailability between Levothyroxine Sodium for Injection…
Lubiprostone
Lubiprostone is a chloride channel activator indicated for the treatment of: chronic idiopathic constipation (CIC) in adults. (1.1) opioid-induced constipation (OIC) in adult patients…